In this episode, we’ll review a report on the KRYSTAL-1 trial of adagrasib therapy in various gastrointestinal cancers, and highlight key points from the newly released AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care.

Coverage of stories discussed this week on ascopost.com:

KRYSTAL-1: Adagrasib Controls Disease in Gastrointestinal Malignancies Beyond Colorectal Cancer

AACR Releases Report on the Impact of COVID-19 on Cancer Research and Patient Care

To listen to more podcasts from ASCO, visit asco.org/podcasts.